The Patent Finder

Rationally Designed, Synthetic Antibody Libraries and Uses Therefor

Adimab, LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application 60/993,785, filed Sep 14, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,008,568Rationally Designed, Synthetic Antibody Libraries and Uses Therefor
In force
 · High confidence
Adimab, LLCIn force
High confidence
US 12,529,164Rationally Designed, Synthetic Antibody Libraries and Uses Therefor
In force
 · Medium confidence
Adimab, LLCIn force
Medium confidence
US 11,008,383Rationally Designed, Synthetic Antibody Libraries and Uses Therefor
In force
 · High confidence
Adimab, LLCIn force
High confidence
US 10,196,635Rationally Designed, Synthetic Antibody Libraries and Uses Therefor
In force
 · Medium confidence
Adimab, LLCIn force
Medium confidence
US 8,691,730Rationally Designed, Synthetic Antibody Libraries and Uses Therefor
In force
 · High confidence
Adimab, LLCIn force
High confidence
US 10,189,894Rationally Designed, Synthetic Antibody Libraries and Uses Therefor
In force
 · High confidence
Adimab, LLCIn force
High confidence
US 8,877,688Rationally Designed, Synthetic Antibody Libraries and Uses Therefor
In force
 · Medium confidence
Adimab, LLCIn force
Medium confidence
Application 17/229,484Rationally Designed, Synthetic Antibody Libraries and Uses Therefor
Abandoned
Abandoned Nov 23, 2021
Adimab, LLCAbandonedAbandoned Nov 23, 2021
Application 17/231,414Rationally Designed, Synthetic Antibody Libraries and Uses Therefor
Abandoned
Abandoned Nov 30, 2021
Adimab, LLCAbandonedAbandoned Nov 30, 2021
Application 17/532,287Rationally Designed, Synthetic Antibody Libraries and Uses Therefor
Abandoned
Abandoned Jul 6, 2022
Adimab, LLCAbandonedAbandoned Jul 6, 2022
2 more patents in this group · Pro
10 of 12 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 12.
Upgrade to Pro
7 of these are in force and held by Adimab, LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited